Together with high PLA2G7 expression in four other metastatic or aggressive tumors, namely, colon, kidney, liver, and lung cancer, Lp‐PLA2 exerted a wider range of significance in cancer progression.18 Hence, clarifying the role of Lp‐PLA2 in cancer progression and even the effectiveness of Lp‐PLA2 as a therapeutic target to manage cancers is meritorious. This evidence concerns the gene PLA2G7 and lung cancer.